drugset / Trial / NCT04517539
Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether stereotactic body radiotherapy (SBRT) combined with recombined human granulocyte-macrophage colony stimulating factor(rhGM-CSF) and Peginterferon alfa-2b is safe, effective in the treatment of patients with metastatic thymic epithelial tumors.
Timeline
- Start
- 2020-12-01
- Primary completion
- 2022-12-01
- Completion
- 2022-12-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Peginterferon alfa-b2 | Protein / enzyme biologic | 90 ug | Subcutaneous |
| Subject | rhGM-CSF | Protein / enzyme biologic | 125 ug/m2 | Subcutaneous |
| Subject | rhGM-CSF | Protein / enzyme biologic | 125 mg/m2 | Subcutaneous |